Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
BIO Statement on the Section 232 Pharmaceutical…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
BIO Statement on Passage of Legislation…
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
All Press Releases
  • Show All
Search
Results
Event Tags
September 6, 2016
BIO launched a new television ad focused on biopharmaceutical innovation and its unique ability to help both save lives and save money.  The new ad, along with its “Innovation Saves” website, is a new chapter in BIO’s Value Campaign, which…
August 18, 2016
Pennsylvania’s concentration of bioscience employment is nine percent greater than national average
August 3, 2016
Meeting will bring together biotechnology executives, academics and investors from around the globe 
August 1, 2016
Programming at this year’s Animal Biotech Summit, Advancing One Health through Biotechnology, will look at how biotechnology can be used in emerging infectious disease surveillance and rapid diagnosis, while highlighting the flexibility…
July 22, 2016
BIO and Pennsylvania Bio commend Governor Tom Wolf for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physicians.
July 15, 2016
Washington, D.C. (July 15, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding the Prescription Drug User Fee Act (PDUFA) VI goals letter:
July 15, 2016
BIO and Nikon Instruments Inc. jointly announce a new partnership under the BIO Business Solutions® offerings.
July 14, 2016
Statement on House Energy & Commerce Committee Passage of H.R. 3299, the Strengthening Public Health Emergency Response Act of 2016
July 14, 2016
Washington, D.C. (July 14, 2016) – The Biotechnology Innovation Organization (BIO) welcomes Congressional passage of a federal, uniform approach to GMO disclosure.  
July 11, 2016
BIO today submitted comments on EPA's proposed Renewable Fuel Standards for 2017, demonstrating that EPA’s interpretation of statutory waiver authority is flawed and its proposed volumes of renewable fuel available for the program are too low and…